Correction to: Oncogene
10.1038/s41388-018-0381-2
This article was originally published under standard licence, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.
. 2019 Jan 8;38(16):3102. doi: 10.1038/s41388-018-0598-0
Correction: Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir–bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death
Charlotte E Johnson
1, Elaine A Dunlop
1, Sara Seifan
1, Henry D McCann
1, Trevor Hay
2, Geraint J Parfitt
2, Ashley T Jones
1, Peter J Giles
1, Ming H Shen
1, Julian R Sampson
1, Rachel J Errington
1, D Mark Davies
1,3, Andrew R Tee
1,✉
Charlotte E Johnson
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Charlotte E Johnson
Elaine A Dunlop
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Elaine A Dunlop
Sara Seifan
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Sara Seifan
Henry D McCann
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Henry D McCann
Trevor Hay
2European Cancer Stem Cell Research Institute, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ UK
Find articles by Trevor Hay
Geraint J Parfitt
2European Cancer Stem Cell Research Institute, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ UK
Find articles by Geraint J Parfitt
Ashley T Jones
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Ashley T Jones
Peter J Giles
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Peter J Giles
Ming H Shen
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Ming H Shen
Julian R Sampson
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Julian R Sampson
Rachel J Errington
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Rachel J Errington
D Mark Davies
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
3Department of Oncology, South West Wales Cancer Centre, Singleton Hospital, Swansea, SA2 8QA UK
Find articles by D Mark Davies
Andrew R Tee
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
Find articles by Andrew R Tee
1Division of Cancer and Genetics, Cardiff University, Heath Park, Cardiff, CF14 4XN UK
2European Cancer Stem Cell Research Institute, Cardiff University, Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ UK
3Department of Oncology, South West Wales Cancer Centre, Singleton Hospital, Swansea, SA2 8QA UK
✉
Corresponding author.
Issue date 2019.
© The Author(s) 2019
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC8075855 PMID: 30622341
This corrects the article "Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir-bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death." with doi: 10.1038/s41388-018-0381-2.